1. Home
  2. RDHL vs CARV Comparison

RDHL vs CARV Comparison

Compare RDHL & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • CARV
  • Stock Information
  • Founded
  • RDHL 2009
  • CARV 1948
  • Country
  • RDHL Israel
  • CARV United States
  • Employees
  • RDHL N/A
  • CARV N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • CARV Savings Institutions
  • Sector
  • RDHL Health Care
  • CARV Finance
  • Exchange
  • RDHL Nasdaq
  • CARV Nasdaq
  • Market Cap
  • RDHL 8.2M
  • CARV 8.8M
  • IPO Year
  • RDHL N/A
  • CARV 1994
  • Fundamental
  • Price
  • RDHL $5.58
  • CARV $1.77
  • Analyst Decision
  • RDHL
  • CARV
  • Analyst Count
  • RDHL 0
  • CARV 0
  • Target Price
  • RDHL N/A
  • CARV N/A
  • AVG Volume (30 Days)
  • RDHL 10.4K
  • CARV 7.9K
  • Earning Date
  • RDHL 04-07-2025
  • CARV 02-18-2025
  • Dividend Yield
  • RDHL N/A
  • CARV N/A
  • EPS Growth
  • RDHL N/A
  • CARV N/A
  • EPS
  • RDHL N/A
  • CARV N/A
  • Revenue
  • RDHL $3,707,000.00
  • CARV $28,323,000.00
  • Revenue This Year
  • RDHL $224.90
  • CARV N/A
  • Revenue Next Year
  • RDHL $82.69
  • CARV N/A
  • P/E Ratio
  • RDHL N/A
  • CARV N/A
  • Revenue Growth
  • RDHL N/A
  • CARV 9.41
  • 52 Week Low
  • RDHL $5.41
  • CARV $1.26
  • 52 Week High
  • RDHL $20.28
  • CARV $2.39
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 35.64
  • CARV 47.45
  • Support Level
  • RDHL $5.50
  • CARV $1.65
  • Resistance Level
  • RDHL $6.26
  • CARV $1.76
  • Average True Range (ATR)
  • RDHL 0.32
  • CARV 0.05
  • MACD
  • RDHL -0.02
  • CARV -0.01
  • Stochastic Oscillator
  • RDHL 3.08
  • CARV 54.55

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About CARV Carver Bancorp Inc.

Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.

Share on Social Networks: